In conclusion, our findings provide new insights into the molecular mechanisms of romidepsin effect on aggressive lymphomas: cell cycle arrest and induction of plasma differentiation is induced upon exposure to the drug and this effect appear to be related to the inhibition of BCL6 expression and function. The gene discussed is BCL6; the disease is lymphoma.